Suppr超能文献

迈向患者决策辅助工具认证的最低标准:一种改进的德尔菲共识过程。

Toward Minimum Standards for Certifying Patient Decision Aids: A Modified Delphi Consensus Process.

作者信息

Joseph-Williams Natalie, Newcombe Robert, Politi Mary, Durand Marie-Anne, Sivell Stephanie, Stacey Dawn, O'Connor Annette, Volk Robert J, Edwards Adrian, Bennett Carol, Pignone Michael, Thomson Richard, Elwyn Glyn

机构信息

Institute of Primary Care and Public Health, Cardiff University, Cardiff, UK (NJ-W, RN, AE, GE)

Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, MO (MP)

出版信息

Med Decis Making. 2014 Aug;34(6):699-710. doi: 10.1177/0272989X13501721. Epub 2013 Aug 20.

Abstract

OBJECTIVE

The IPDAS Collaboration has developed a checklist and an instrument (IPDASi v3.0) to assess the quality of patient decision aids (PDAs) in terms of their development process and shared decision-making design components. Certification of PDAs is of growing interest in the US and elsewhere. We report a modified Delphi consensus process to agree on IPDASi (v3.0) items that should be considered as minimum standards for PDA certification, for inclusion in the refined IPDASi (v4.0).

METHODS

A 2-stage Delphi voting process considered the inclusion of IPDASi (v3.0) items as minimum standards. Item scores and qualitative comments were analyzed, followed by expert group discussion.

RESULTS

One hundred and one people voted in round 1; 87 in round 2. Forty-seven items were reduced to 44 items across 3 new categories: 1) qualifying criteria, which are required in order for an intervention to be considered a decision aid (6 items); 2) certification criteria, without which a decision aid is judged to have a high risk of harmful bias (10 items); and 3) quality criteria, believed to strengthen a decision aid but whose omission does not present a high risk of harmful bias (28 items).

CONCLUSIONS

This study provides preliminary certification criteria for PDAs. Scoring and rating processes need to be tested and finalized. However, the process of appraising the quality of the clinical evidence reported by the PDA should be used to complement these criteria; the proposed standards are designed to rate the quality of the development process and shared decision-making design elements, not the quality of the PDA's clinical content.

摘要

目的

国际患者决策辅助标准协作组(IPDAS Collaboration)已制定了一份清单和一种工具(IPDASi v3.0),用于从患者决策辅助工具(PDA)的开发过程和共享决策设计组件方面评估其质量。在美国和其他地区,PDA的认证越来越受到关注。我们报告了一个经过修改的德尔菲共识过程,以就IPDASi(v3.0)的项目达成一致,这些项目应被视为PDA认证的最低标准,以便纳入完善后的IPDASi(v4.0)。

方法

采用两阶段德尔菲投票过程来考虑将IPDASi(v3.0)项目纳入最低标准。对项目得分和定性评论进行了分析,随后进行了专家组讨论。

结果

第一轮有101人投票;第二轮有87人投票。47个项目被缩减为44个项目,分为3个新类别:1)资格标准,这是一项干预措施被视为决策辅助工具所必需的条件(6项);2)认证标准,没有这些标准,决策辅助工具被判定存在有害偏倚的高风险(10项);3)质量标准,被认为可加强决策辅助工具,但遗漏这些标准不会带来有害偏倚的高风险(28项)。

结论

本研究提供了PDA的初步认证标准。评分和评级过程需要进行测试并最终确定。然而,评估PDA所报告临床证据质量的过程应用于补充这些标准;所提议的标准旨在对开发过程和共享决策设计要素的质量进行评级,而非PDA临床内容的质量。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验